{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:01:46Z","timestamp":1792101706019,"version":"4.4.0"},"reference-count":50,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2008,8,9]],"date-time":"2008-08-09T00:00:00Z","timestamp":1218240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cellular Molecular Medi"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autism spectrum disorders (ASDs), which include the prototypic autistic disorder (AD), Asperger\u2019s syndrome (AS) and pervasive developmental disorders not otherwise specified (PDD\u2010NOS), are complex neurodevelopmental conditions of unknown aetiology. The current study investigated the metabolites in the methionine cycle, the transsulphuration pathway, folate, vitamin B<jats:sub>12<\/jats:sub> and the C677T polymorphism of the MTHFR gene in three groups of children diagnosed with AD (<jats:italic>n<\/jats:italic>= 15), AS (<jats:italic>n<\/jats:italic>= 5) and PDD\u2010NOS (<jats:italic>n<\/jats:italic>= 19) and their age\u2010 and sex\u2010matched controls (<jats:italic>n<\/jats:italic>= 25). No metabolic disturbances were seen in the AS patients, while in the AD and PDD\u2010NOS groups, lower plasma levels of methionine (<jats:italic>P<\/jats:italic>= 0.01 and <jats:italic>P<\/jats:italic>= 0.03, respectively) and \u03b1\u2010aminobutyrate were observed (<jats:italic>P<\/jats:italic>= 0.01 and <jats:italic>P<\/jats:italic>= 0.001, respectively). Only in the AD group, plasma cysteine (<jats:italic>P<\/jats:italic>= 0.02) and total blood glutathione (<jats:italic>P<\/jats:italic>= 0.02) were found to be reduced. Although there was a trend towards lower levels of serine, glycine, N, N\u2010dimethylglycine in AD patients, the plasma levels of these metabolites as well as the levels of homocysteine and cystathionine were not statistically different in any of the ASDs groups. The serum levels of vitamin B<jats:sub>12<\/jats:sub> and folate were in the normal range. The results of the MTHFR gene analysis showed a normal distribution of the C677T polymorphism in children with ASDs, but the frequency of the 677T allele was slightly more prevalent in AD patients. Our study indicates a possible role for the alterations in one carbon metabolism in the pathophysiology of ASDs and provides, for the first time, preliminary evidence for metabolic and genetic differences between clinical subtypes of ASDs.<\/jats:p>","DOI":"10.1111\/j.1582-4934.2008.00463.x","type":"journal-article","created":{"date-parts":[[2008,8,9]],"date-time":"2008-08-09T12:51:18Z","timestamp":1218286278000},"page":"4229-4238","source":"Crossref","is-referenced-by-count":95,"title":["One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders"],"prefix":"10.1111","volume":"13","author":[{"given":"Sergiu P.","family":"Pa\u015fca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Dronca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Kaucs\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena C.","family":"Cr\u01ceciun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Em\u00f5ke","family":"Endreffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix K.","family":"Ferencz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Iftene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"Benga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodica","family":"Cornean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruma","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dronca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14471-6"},{"key":"e_1_2_6_3_2","volume-title":"Diagnostic and Statistical Manual\u2010Text Revision","author":"American Psychiatric Association","year":"2000"},{"key":"e_1_2_6_4_2","first-page":"12","article-title":"Prevalence of autism spectrum disorders\u2010autism and developmental disabilities monitoring network, 14 sites, United States, 2002","volume":"56","author":"Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators, Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Surveill Summ."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69041-7"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.06.020"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2006.05.010"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2007.01.009"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn1770"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/0883073807308698"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/80.6.1611"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30366"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.lfs.2005.09.040","article-title":"High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism","volume":"78","author":"Pa\u00fcsca SP","year":"2006","journal-title":"Life Sci."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000094467"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-007-0492-z"},{"key":"e_1_2_6_16_2","first-page":"106","article-title":"Association of MTHFR gene variants with autism","volume":"9","author":"Boris M","year":"2004","journal-title":"J Am Phys Surg"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2007.09.010"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.3844\/ajbbsp.2008.105.113"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2007.05.025"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11064-008-9888-1","article-title":"A prospective study of transsulfuration biomarkers in autistic disorders","volume":"34","author":"Geier DA","year":"2009","journal-title":"Neurochem Res"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathophys.2006.05.007"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.12.3404.3404"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113343"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2144\/99272bm04","article-title":"High\u2010speed prothrombin G\u2013>A 20210 and methylenetetrahydrofolate reductase C\u2013>T 677 mutation detection using real\u2010time fluorescence PCR and melting curves","volume":"27","author":"Aslanidis C","year":"1999","journal-title":"Biotechniques."},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23318"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200402000-00012"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl213"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1079\/NRR2006119"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2006.02.001"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012221026124"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025071014191"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.07.013"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1657581"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1177\/1362361302006001008"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2007.03.004"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01531294"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2006.12.59"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2004.10.1033"},{"key":"e_1_2_6_39_2","first-page":"565","article-title":"A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies","volume":"28","author":"Geier DA","year":"2007","journal-title":"Neuro Endocrinol Lett."},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2007.1712"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00171.2007"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00337-0"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.5271\/sjweh.2239"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2006.04.008"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1080\/15287390701457712"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033334"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-006-0121-2"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.07.004"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.22.010402.102932"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1420-9101.2006.01091.x"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.05.023"}],"container-title":["Journal of Cellular and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1582-4934.2008.00463.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1582-4934.2008.00463.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T21:25:43Z","timestamp":1697318743000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1582-4934.2008.00463.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1582-4934.2008.00463.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00463.x","archive":["Portico"],"relation":{},"ISSN":["1582-1838","1582-4934"],"issn-type":[{"value":"1582-1838","type":"print"},{"value":"1582-4934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}